# DexCom, Inc. clinical trials: 35 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 35 trials with DexCom, Inc. as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by DexCom, Inc.: 35 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/dexcom-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 35
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 35, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 2, 2026 | NCT07681375 | Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor | DexCom, Inc. | Phase 1 | Active not recruiting | Type 2 Diabetes | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07681375) |
| July 2, 2026 | NCT07681024 | Global Long-term Outcomes and Real-World Evaluation of Dexcom Continuous Glucose Monitoring System (Dexcom GLOW) | DexCom, Inc. | Observational | Not yet recruiting | Diabetes | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07681024) |
| May 22, 2026 | NCT07603284 | Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi Arabia | DexCom, Inc. | Phase 4 | Active not recruiting | Type 2 Diabetes on Insulin | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07603284) |
| September 19, 2024 | NCT06601166 | CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin | DexCom, Inc. | Not applicable | Active not recruiting | Type 2 Diabetes | 283 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06601166) |
| July 3, 2024 | NCT06483945 | Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry) | DexCom, Inc. | Observational | Active not recruiting | Diabetes | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06483945) |
| February 27, 2023 | NCT05746286 | Remote Monitoring of Vital Signs With Telehealth to Prevent Readmissions for Dysglycemia | DexCom, Inc. | Not applicable | Completed | Dysglycemia | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05746286) |
| May 27, 2021 | NCT04905628 | Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus | DexCom, Inc. | Observational | Unknown | Diabetes Mellitus | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04905628) |
| May 10, 2021 | NCT04879693 | Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System in Non-Critically Ill Patients in the Inpatient Setting | DexCom, Inc. | Not applicable | Unknown | Patients Needing Glucose Control | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04879693) |
| April 12, 2021 | NCT04840446 | Evaluation of Modified Adhesives With Dexcom G6 Sensor | DexCom, Inc. | Observational | Completed | Diabetes | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04840446) |
| March 12, 2021 | NCT04794478 | Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System | DexCom, Inc. | Not applicable | Completed | Diabetes Mellitus | 482 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04794478) |
| November 27, 2020 | NCT04645641 | Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System | DexCom, Inc. | Not applicable | Unknown | Diabetes Mellitus | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04645641) |
| October 14, 2020 | NCT04585139 | Assessing Non-adjunctive CGM Safety at Home and in New Markets | DexCom, Inc. | Not applicable | Completed | Diabetes Mellitus | 85 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04585139) |
| August 28, 2020 | NCT04529824 | Glucose Risk Assessment in Employer Populations | DexCom, Inc. | Observational | Completed | Diabetes, Pre-diabetes, Glucose Intolerance | 207 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04529824) |
| August 7, 2020 | NCT04503239 | Prediabetes and Type 2 Diabetes Data Collection Study | DexCom, Inc. | Observational | Unknown | Diabetes Mellitus, Type 2, Pre-diabetes | 306 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04503239) |
| May 2, 2019 | NCT03935191 | Performance of the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus | DexCom, Inc. | Observational | Unknown | Diabetes | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03935191) |
| August 8, 2018 | NCT03620357 | Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) | DexCom, Inc. | Not applicable | Completed | Diabetes Mellitus, Type 2 | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03620357) |
| June 25, 2018 | NCT03566693 | Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE) | DexCom, Inc. | Not applicable | Completed | Diabetes Mellitus, Type 2 | 176 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03566693) |
| November 14, 2017 | NCT03340831 | Continuous Monitoring and Control of Hypoglycemia | DexCom, Inc. | Observational | Unknown | Diabetes | 1,388 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03340831) |
| March 23, 2017 | NCT03087877 | Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor | DexCom, Inc. | Not applicable | Completed | Diabetes Mellitus | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03087877) |
| August 26, 2016 | NCT02880267 | Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System | DexCom, Inc. | Not applicable | Completed | Diabetes Mellitus | 304 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02880267) |
| March 2, 2016 | NCT02696252 | G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator | DexCom, Inc. | Observational | Completed | Diabetes Mellitus | 97 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02696252) |
| February 16, 2015 | NCT02363907 | Observational Study to Evaluate the Effectiveness and Safety of the Dexcom G4 Continuous Glucose Monitoring System in Pediatrics | DexCom, Inc. | Observational | Completed | Diabetes Mellitus | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02363907) |
| November 4, 2014 | NCT02282397 | Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes | DexCom, Inc. | Not applicable | Completed | Diabetes Mellitus | 316 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02282397) |
| March 14, 2014 | NCT02087995 | Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm | DexCom, Inc. | Not applicable | Completed | Diabetes Mellitus | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02087995) |
| August 17, 2012 | NCT01667185 | Effectiveness and Safety of the Dexcom™ G4 Continuous Glucose Monitoring System in Pediatric Subjects With Diabetes Mellitus | DexCom, Inc. | Observational | Completed | Pediatric Subjects With Diabetes Mellitus | 176 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01667185) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 4 | 1 |
| Not applicable | 14 |
| Observational | 19 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 24 |
| Unknown | 6 |
| Active not recruiting | 4 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus | 27 |
| Diabetes Mellitus, Type 2 | 6 |
| Diabetes Mellitus, Type 1 | 3 |
| Glucose Intolerance | 2 |
| Hyperglycemia | 1 |
| Insulin Resistance | 1 |
| Endocrine System Diseases | 1 |
| Glucose Metabolism Disorders | 1 |
| Metabolic Diseases | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B newspaper advertising companies in the United States](https://specstream.ai/data/businesses/b2b-newspaper-advertising-companies/united-states)
- [Colombian restaurants in the United States](https://specstream.ai/data/businesses/colombian-restaurants/united-states)
- [Farming services in the United States](https://specstream.ai/data/businesses/farming-services/united-states)
- [Insurance agencies in the United States](https://specstream.ai/data/businesses/insurance-agencies/united-states)
- [Occupational therapy clinics in the United States](https://specstream.ai/data/businesses/occupational-therapy-clinics/united-states)
- [Restaurant equipment suppliers in the United States](https://specstream.ai/data/businesses/restaurant-equipment-suppliers/united-states)
